Tag: US Food and Drug Administration

November 13, 2019

ReWalk Robotics Hits All-time Low Following Q3 Earnings

With sales of its exoskeleton slumping nearly 50 percent year-over-year, ReWalk missed its earnings per share target from analysts.
November 13, 2019

Clovis Oncology’s Rubraca Available for Reimbursement in Italy

Rubraca is eligible for reimbursement in various countries in Europe, and Clovis is looking at doing the same in more...
November 12, 2019

NantHealth Gets FDA Authorization for Omics Core Test

Shares of NantHealth rose over 10 percent following the news that the FDA has granted it marketing authorization for its...
November 12, 2019

Aptinyx Begins Two Phase 2 Studies of NYX-2925

The company is evaluating its NYX-2925 treatment in painful diabetic peripheral neuropathy and fibromyalgia.
November 8, 2019

Celgene Receives FDA Approval for REBLOZYL

REBLOZYL is the first FDA-approved treatment of anemia in adults with beta thalassemia that require red blood cell transfusions.
November 6, 2019

Crescita Gets FDA Approval for Enhanced Formulation of Pliaglis

The company received approval from the US Food and Drug Administration for the enhanced formulation of its topical treatment Pliaglis.
November 5, 2019

Autolus Therapeutics Rises on FDA Orphan Drug Designation

Shares of the company spiked over 10 percent during Tuesday's trading session after its drug received orphan drug designation from...